Isthmus Partners LLC Has $10.76 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Isthmus Partners LLC reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,851 shares of the company’s stock after selling 122 shares during the quarter. Isthmus Partners LLC’s holdings in HCA Healthcare were worth $10,761,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. FMR LLC boosted its position in HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after buying an additional 2,397,883 shares in the last quarter. Franklin Resources Inc. lifted its position in HCA Healthcare by 11.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after buying an additional 174,946 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in HCA Healthcare by 2.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after acquiring an additional 41,190 shares in the last quarter. Janus Henderson Group PLC lifted its position in shares of HCA Healthcare by 12.0% during the third quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock worth $544,467,000 after purchasing an additional 143,995 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in HCA Healthcare by 0.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,149,043 shares of the company’s stock worth $344,885,000 after purchasing an additional 6,590 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 2.6 %

HCA Healthcare stock opened at $330.11 on Monday. The company has a 50 day moving average of $316.70 and a 200-day moving average of $347.29. The stock has a market capitalization of $81.27 billion, a PE ratio of 15.03, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the firm posted $5.90 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.87%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is currently 13.11%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research firms have recently weighed in on HCA. KeyCorp dropped their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Barclays reduced their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. Bank of America cut their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Finally, Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.